Helix Nanotechnologies

Next-generation mRNA platform to solve cancer, COVID and climate.

Boston, United States · $45.0M raised

Employees
11–50
Total Funding
$45.0M
Last Round
$45.0M Series AMar 2022
Rounds
1

About

Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech — moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.

Summary

Helix Nanotechnologies is an Artificial Intelligence company based in Boston, United States. It has raised $45.0M in total across 1 round, most recently a $45.0M Series A round in Mar 2022. Investors include Starlight Ventures, Founders Fund and DCVC (Data Collab).

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AMar 2022
$45.0M

Investors

Similar Companies